These data prompted us to hypothesize that, in the peripheral/neuronal differentiated GBM samples, HIF-1α may primarily act as a co-factor of the Wnt pathway, rather than activating its recognized target genes, thus actively participating in the enhancement of the Wnt signaling-dependent neuronal differentiation process. The gene discussed is HIF1A; the disease is glioblastoma.